Role of increased DNA replication in the carcinogenic risk of nonmutagenic chemical carcinogens - PubMed (original) (raw)
Review
Role of increased DNA replication in the carcinogenic risk of nonmutagenic chemical carcinogens
M L Cunningham. Mutat Res. 1996 Sep.
Abstract
DNA replication is not an error-free process; therefore induction of cell proliferation with the requisite increase in DNA replication may be an important mechanism by which carcinogenesis can be induced by chemicals. Data presented in this overview indicate a positive association between increased cell proliferation and carcinogenesis, and illustrate the value of performing mechanistic studies such as cell proliferation assays in conjunction with short-term tests to further investigate the results of cancer bioassays. Whereas chemically-induced cell proliferation per se may not be sufficient to induce carcinogenesis, it creates a favorable environment for tumor development. There are two types of chemically-induced cell proliferation, mitogenic and cytotoxic, and they have different consequences regarding the mechanism of carcinogenesis of a chemical. Mitogenic chemical such as phenobarbital, oxazepam, and the peroxisome proliferating agents exert a short-term cell proliferative response that may exert its primary effect in carcinogenesis at the promotion stages. It is not clear at what stage(s) cytotoxic agents such as methapyrilene, alpha 2u-globulin inducers or saccharin exert their effects in carcinogenesis. A confounding factor in evaluation of cell proliferation in risk assessments is the production of chemical specific pleiotropic effects that may contribute to the carcinogenicity of a chemical. It is clear that mechanistic studies performed to understand the relationship of sex, species and dose in rodent carcinogenicity assays of chemicals is critical for the extrapolation of such data for human health assessments.
Similar articles
- Liver carcinogenesis is not a predicted outcome of chemically induced hepatocyte proliferation.
Melnick RL, Huff J. Melnick RL, et al. Toxicol Ind Health. 1993 May-Jun;9(3):415-38. doi: 10.1177/074823379300900303. Toxicol Ind Health. 1993. PMID: 8367884 Review. - Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
Gaylor DW. Gaylor DW. Regul Toxicol Pharmacol. 2005 Mar;41(2):128-33. doi: 10.1016/j.yrtph.2004.11.001. Epub 2004 Dec 19. Regul Toxicol Pharmacol. 2005. PMID: 15698536 - Does chemically induced hepatocyte proliferation predict liver carcinogenesis?
Melnick RL. Melnick RL. FASEB J. 1992 Jun;6(9):2698-706. doi: 10.1096/fasebj.6.9.1612294. FASEB J. 1992. PMID: 1612294 Review. - Guidelines for measuring chemically induced cell proliferation in specific rodent target organs.
Goldsworthy TL, Morgan KT, Popp JA, Butterworth BE. Goldsworthy TL, et al. Prog Clin Biol Res. 1991;369:253-84. Prog Clin Biol Res. 1991. PMID: 1946524 - Mechanistically-based human hazard assessment of peroxisome proliferator-induced hepatocarcinogenesis.
Ashby J, Brady A, Elcombe CR, Elliott BM, Ishmael J, Odum J, Tugwood JD, Kettle S, Purchase IF. Ashby J, et al. Hum Exp Toxicol. 1994 Nov;13 Suppl 2:S1-117. doi: 10.1177/096032719401300201. Hum Exp Toxicol. 1994. PMID: 7857698 Review.
Cited by
- Correct Identification of Cell of Origin May Explain Many Aspects of Cancer: The Role of Neuroendocrine Cells as Exemplified from the Stomach.
Waldum H, Mjønes PG. Waldum H, et al. Int J Mol Sci. 2020 Aug 11;21(16):5751. doi: 10.3390/ijms21165751. Int J Mol Sci. 2020. PMID: 32796591 Free PMC article. Review. - The H19 Long non-coding RNA in cancer initiation, progression and metastasis - a proposed unifying theory.
Raveh E, Matouk IJ, Gilon M, Hochberg A. Raveh E, et al. Mol Cancer. 2015 Nov 4;14:184. doi: 10.1186/s12943-015-0458-2. Mol Cancer. 2015. PMID: 26536864 Free PMC article. Review. - Computational modeling identifies key gene regulatory interactions underlying phenobarbital-mediated tumor promotion.
Luisier R, Unterberger EB, Goodman JI, Schwarz M, Moggs J, Terranova R, van Nimwegen E. Luisier R, et al. Nucleic Acids Res. 2014 Apr;42(7):4180-95. doi: 10.1093/nar/gkt1415. Epub 2014 Jan 23. Nucleic Acids Res. 2014. PMID: 24464994 Free PMC article. - Hepatocellular carcinomas in B6C3F1 mice treated with Ginkgo biloba extract for two years differ from spontaneous liver tumors in cancer gene mutations and genomic pathways.
Hoenerhoff MJ, Pandiri AR, Snyder SA, Hong HH, Ton TV, Peddada S, Shockley K, Witt K, Chan P, Rider C, Kooistra L, Nyska A, Sills RC. Hoenerhoff MJ, et al. Toxicol Pathol. 2013 Aug;41(6):826-41. doi: 10.1177/0192623312467520. Epub 2012 Dec 21. Toxicol Pathol. 2013. PMID: 23262642 Free PMC article. - A mouse model of hepatocellular carcinoma: ectopic expression of fibroblast growth factor 19 in skeletal muscle of transgenic mice.
Nicholes K, Guillet S, Tomlinson E, Hillan K, Wright B, Frantz GD, Pham TA, Dillard-Telm L, Tsai SP, Stephan JP, Stinson J, Stewart T, French DM. Nicholes K, et al. Am J Pathol. 2002 Jun;160(6):2295-307. doi: 10.1016/S0002-9440(10)61177-7. Am J Pathol. 2002. PMID: 12057932 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources